Melanoma Clinical Trials

A listing of Melanoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 756 clinical trials
  • 0 views
  • 14 May, 2022
  • 5 locations
A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma

Approximately 40 participants with locally advanced or metastatic melanoma will be enrolled in 20 sites in the United States into 1 of the following 2 arms: Primary resistance to initial

  • 0 views
  • 17 Sep, 2022
  • 13 locations
Nab-PCE vs PC for MM After Failure of Anti-PD-1

This is a randomized controlled clinical trial of nab-paclitaxel + carboplatin Endostatin for advanced melanoma after failure of PD-1 therapy. The aim was to evaluate the efficacy

renal function
metastasis
measurable disease
brain metastases
  • 0 views
  • 03 Feb, 2022
  • 1 location
  • 1 views
  • 23 Sep, 2022
  • 8 locations
  • 0 views
  • 24 Jan, 2021
  • 1 location
  • 0 views
  • 20 Aug, 2022
  • 9 locations
CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer

in a variety of tumors, including melanoma, pancreatic cancer, breast cancer, prostate cancer, colorectal cancer and other tumors, and its expression level is closely related to the poor prognosis

  • 0 views
  • 09 Dec, 2021
  • 1 location
Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy (COWBOY)

Rationale The combination of ipilimumab and nivolumab induces relatively high response rates and promising response depth in late stage melanoma. Nevertheless, it

  • 33 views
  • 24 Feb, 2022
  • 10 locations
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

preliminary antitumor activity, will be evaluated in patients with soft tissue sarcoma (Part 2, Cohort1), whereas in melanoma patients, anti-tumor activity will be defined as a primary objective (Part 2

  • 7 views
  • 24 Apr, 2022
  • 2 locations
A Phase 1/2 Study of ASP1570 in Participants With Locally Advanced or Metastatic Solid Tumors

Part 1 without getting major medical problems. Some groups of people will have specific advanced tumors. These include tumors from metastatic melanoma or non-small cell lung cancer (NSCLC for short

  • 1 views
  • 16 Sep, 2022
  • 10 locations